205 related articles for article (PubMed ID: 33167076)
1. Prognostic impact of non-urothelial carcinoma of the upper urinary tract: Analysis of hospital-based cancer registry data in Japan.
Nagumo Y; Kawai K; Kojima T; Shiga M; Kojo K; Tanaka K; Kandori S; Kimura T; Kawahara T; Okuyama A; Higashi T; Nishiyama H
Int J Urol; 2021 Jan; 28(1):54-60. PubMed ID: 33167076
[TBL] [Abstract][Full Text] [Related]
2. Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.
Shiga M; Nagumo Y; Chihara I; Nitta S; Kojo K; Kimura T; Kandori S; Kojima T; Okuyama A; Higashi T; Nishiyama H
Int J Urol; 2021 Aug; 28(8):814-819. PubMed ID: 34013614
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
4. Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
Inokuchi J; Naito S; Fujimoto H; Hara T; Sakura M; Nishiyama H; Miyazaki J; Kikuchi E; Hinotsu S; Koie T; Ohyama C;
Int J Urol; 2016 Mar; 23(3):224-30. PubMed ID: 26659912
[TBL] [Abstract][Full Text] [Related]
5. Modified Glasgow prognostic score is a pre-surgical prognostic marker of disease mortality in upper urinary tract urothelial carcinoma.
Tsuzuki S; Kimura S; Fukuokaya W; Yanagisawa T; Hata K; Miki J; Kimura T; Abe H; Egawa S
Jpn J Clin Oncol; 2021 Jan; 51(1):138-144. PubMed ID: 32728722
[TBL] [Abstract][Full Text] [Related]
6. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
[TBL] [Abstract][Full Text] [Related]
7. Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan-Japan UTUC Collaboration Cohort.
Luo HL; Ohyama C; Hatakeyama S; Wang HJ; Yoneyama T; Yang WC; Chuang YC; Chen YT; Lee WC; Cheng YT; Kang CH; Chiang PH
Int J Urol; 2020 Apr; 27(4):327-332. PubMed ID: 32100370
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of non-urothelial carcinoma of bladder: analysis of nationwide hospital-based cancer registry data in Japan.
Nagumo Y; Kawai K; Kojima T; Shiga M; Kojo K; Tanaka K; Kandori S; Kimura T; Kawahara T; Okuyama A; Higashi T; Nishiyama H
Jpn J Clin Oncol; 2020 Sep; 50(9):1068-1075. PubMed ID: 32469066
[TBL] [Abstract][Full Text] [Related]
9. Editorial Comment to Prognostic impact of non-urothelial carcinoma of the upper urinary tract: Analysis of hospital-based cancer registry data in Japan.
Hayakawa N; Kikuchi E
Int J Urol; 2021 Jan; 28(1):60-61. PubMed ID: 33167070
[No Abstract] [Full Text] [Related]
10. Editorial Comment from Dr Sazuka to Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.
Sazuka T
Int J Urol; 2021 Aug; 28(8):820-821. PubMed ID: 34013556
[No Abstract] [Full Text] [Related]
11. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163
[TBL] [Abstract][Full Text] [Related]
13. Editorial Comment from Dr Setoguchi and Dr Saito to Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.
Setoguchi K; Saito K
Int J Urol; 2021 Aug; 28(8):821-822. PubMed ID: 34169599
[No Abstract] [Full Text] [Related]
14. Comparative analysis of patients with upper urinary tract urothelial carcinoma in black-foot disease endemic and non-endemic area.
Chang CW; Ou CH; Yu CC; Lo CW; Tsai CY; Cheng PY; Chen YT; Huang HC; Wu CC; Li CC; Lee HY
BMC Cancer; 2021 Jan; 21(1):80. PubMed ID: 33468084
[TBL] [Abstract][Full Text] [Related]
15. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
[TBL] [Abstract][Full Text] [Related]
16. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
[TBL] [Abstract][Full Text] [Related]
17. Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association.
Koie T; Ohyama C; Fujimoto H; Nishiyama H; Miyazaki J; Hinotsu S; Kikuchi E; Sakura M; Inokuchi J; Hara T; ; Ohyama C; Nishiyama H; Fujisawa M; Uemura H; Fujimoto H; Suzuki K; Eto M; Hara I; Matsubara A; Nonomura N; Nakanishi H; Koie T; Kanayama H; Miki T; Fukumori T; Naito S;
Jpn J Clin Oncol; 2016 May; 46(5):468-74. PubMed ID: 26851754
[TBL] [Abstract][Full Text] [Related]
18. Urothelial Carcinoma of the Renal Pelvis and Ureter: Does Location Make a Difference?
Lwin AA; Hsu CH; Chipollini J
Clin Genitourin Cancer; 2020 Feb; 18(1):45-49.e1. PubMed ID: 31786118
[TBL] [Abstract][Full Text] [Related]
19. Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.
Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
World J Urol; 2019 Jul; 37(7):1329-1337. PubMed ID: 30298285
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Pyuria Is a Poor Prognostic Factor in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Surgery.
Yoshida T; Kinoshita H; Shimada S; Sugi M; Matsuda T
Clin Genitourin Cancer; 2017 Aug; 15(4):e543-e550. PubMed ID: 28110834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
